Creatinine normal OR creatinine clearance ≥ 60 mL/min [clinicaltrials_resource:07435e40812ff9a5e515fd3508e5ecba]
eligibility for clinicaltrials:NCT00243100 [clinicaltrials_resource:24fb89778904fb6121722f014396d70e]eligibility for clinicaltrials:NCT00535119 [clinicaltrials_resource:4c77e456d086e01835c1eb35ff41f1ef]eligibility for clinicaltrials:NCT02076477 [clinicaltrials_resource:8213ba7b1c59030c5a69d8a40a6a69ea]eligibility for clinicaltrials:NCT02399306 [clinicaltrials_resource:d6070c3db829db1cddd89a678fdd05a0]eligibility for clinicaltrials:NCT00521144 [clinicaltrials_resource:e586ce5a576957a40fc4d25db64c11b1]eligibility for clinicaltrials:NCT01189240 [clinicaltrials_resource:f292e36d7649aaff378d04dd9295507a]eligibility for clinicaltrials:NCT00607594 [clinicaltrials_resource:f2c6912e8ea857b1b1e62618397a1061]eligibility for clinicaltrials:NCT00800917 [clinicaltrials_resource:f7e46071590fd26926ddcfc3a1de2fb9]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00293345 [clinicaltrials_resource:019ddd3b411c35d757fce9df4bf71d52]eligibility for clinicaltrials:NCT01234532 [clinicaltrials_resource:13f04109fdc44e6a3b903e8502066340]eligibility for clinicaltrials:NCT00243100 [clinicaltrials_resource:24fb89778904fb6121722f014396d70e]eligibility for clinicaltrials:NCT00397982 [clinicaltrials_resource:422a56b97fe6a12493aa502f71781d82]eligibility for clinicaltrials:NCT01149356 [clinicaltrials_resource:4639f94b21372c66926dcaf5667a221a]eligibility for clinicaltrials:NCT00535119 [clinicaltrials_resource:4c77e456d086e01835c1eb35ff41f1ef]eligibility for clinicaltrials:NCT00559949 [clinicaltrials_resource:4ce0b88c862581ef4aa4b58ab4db3162]eligibility for clinicaltrials:NCT00305773 [clinicaltrials_resource:522100cc569c33c58494ddc7d6638f8d]eligibility for clinicaltrials:NCT00643240 [clinicaltrials_resource:53525b80661318c8ca82a3882a97ec0a]eligibility for clinicaltrials:NCT00301756 [clinicaltrials_resource:5be956883f0e12d02fa5f13b3bd89e15]eligibility for clinicaltrials:NCT00475150 [clinicaltrials_resource:5ca10f2b6dd87406e1db2a4c248d1d41]eligibility for clinicaltrials:NCT00735917 [clinicaltrials_resource:6426f73d7e97ea053f384adaa0b1bf3b]eligibility for clinicaltrials:NCT00567931 [clinicaltrials_resource:70d159a5fc52a46ee1cf665a12880423]eligibility for clinicaltrials:NCT00407810 [clinicaltrials_resource:7245e5eac45332ea96e74e7cc6bdd647]eligibility for clinicaltrials:NCT00326872 [clinicaltrials_resource:73ca1283e77af9844082e47a1599e117]eligibility for clinicaltrials:NCT01208441 [clinicaltrials_resource:77a8cc786884bbadb31e93e0be5f782b]eligibility for clinicaltrials:NCT00471536 [clinicaltrials_resource:782e60bc926cb3bc371885b894cba6d6]eligibility for clinicaltrials:NCT01105377 [clinicaltrials_resource:788621d8fd5fc0831ef61b21da7cb30d]eligibility for clinicaltrials:NCT00454142 [clinicaltrials_resource:7a8c9058e54f4f064940e6a408cca59f]eligibility for clinicaltrials:NCT00669019 [clinicaltrials_resource:7cf3bbf823e870fd139321fc06a6bbc9]eligibility for clinicaltrials:NCT00278382 [clinicaltrials_resource:81205923af8ff72d0138b4c7f16cb2d3]eligibility for clinicaltrials:NCT02076477 [clinicaltrials_resource:8213ba7b1c59030c5a69d8a40a6a69ea]eligibility for clinicaltrials:NCT00227513 [clinicaltrials_resource:827bcee86f22b922d8bb60b458610c08]eligibility for clinicaltrials:NCT00138177 [clinicaltrials_resource:8f4424436ef267818d1b39a76b673c61]eligibility for clinicaltrials:NCT01232829 [clinicaltrials_resource:8faae1d0e968a46c2c27deb112ac91dd]eligibility for clinicaltrials:NCT00324480 [clinicaltrials_resource:9157402b5799a41d792ebe0abbd0befe]eligibility for clinicaltrials:NCT00662506 [clinicaltrials_resource:ad697911851faf266d1097ccd0fd149a]eligibility for clinicaltrials:NCT01191216 [clinicaltrials_resource:b4b1e5e8ff92a0903549567ce6d8035f]eligibility for clinicaltrials:NCT00331682 [clinicaltrials_resource:c8322dc2060a312aac51c3ffe3b8b2f8]eligibility for clinicaltrials:NCT02399306 [clinicaltrials_resource:d6070c3db829db1cddd89a678fdd05a0]eligibility for clinicaltrials:NCT00859937 [clinicaltrials_resource:e4d262d010ab4b99ac63309f6836fa6e]eligibility for clinicaltrials:NCT00521144 [clinicaltrials_resource:e586ce5a576957a40fc4d25db64c11b1]eligibility for clinicaltrials:NCT00559377 [clinicaltrials_resource:e90e555bdc55003931084ae5f3854a41]eligibility for clinicaltrials:NCT01189240 [clinicaltrials_resource:f292e36d7649aaff378d04dd9295507a]eligibility for clinicaltrials:NCT00607594 [clinicaltrials_resource:f2c6912e8ea857b1b1e62618397a1061]eligibility for clinicaltrials:NCT00559507 [clinicaltrials_resource:f6646ae415b0110e4405ff48005d42ba]eligibility for clinicaltrials:NCT00800917 [clinicaltrials_resource:f7e46071590fd26926ddcfc3a1de2fb9]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Creatinine normal OR creatinine clearance ≥ 60 mL/min [clinicaltrials_resource:07435e40812ff9a5e515fd3508e5ecba]
Bio2RDF identifier
07435e40812ff9a5e515fd3508e5ecba
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:07435e40812ff9a5e515fd3508e5ecba
identifier
clinicaltrials_resource:07435e40812ff9a5e515fd3508e5ecba
title
Creatinine normal OR creatinine clearance ≥ 60 mL/min
@en
type
label
Creatinine normal OR creatinin ...... 35e40812ff9a5e515fd3508e5ecba]
@en